We conducted a hospital-based case–control study of 277 patients with primary lung cancer and 496 controls without a history of cancer, all of them Austrian Caucasians, to investigate whether the mEH polymorphisms in exons 3 and 4 are associated with lung cancer risk. The gene discussed is EPHX1; the disease is lung cancer.